𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ADAMTS1, a putative anti-angiogenic factor, is decreased in human prostate cancer

✍ Scribed by Heléne Gustavsson; Wanzhong Wang; Karin Jennbacken; Karin Welén; Jan-Erik Damber


Book ID
109055957
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
393 KB
Volume
104
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Angiogenic factor VEGF is decreased in h
✍ Wynter, Coral V. A.; Simms, Lisa A.; Buttenshaw, Ron L.; Biden, Kelli G.; Young, 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 1 views

Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) are two important determinants of angiogenesis in human cancers. Expression of VEGF and bFGF was examined by immunohistochemistry in 120 colorectal cancers. ## Neoplasms were classified according to the presence or

Epidermal growth factor induces cyclin D
✍ Perry, Jaime E.; Grossmann, Michael E.; Tindall, Donald J. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB 👁 2 views

## BACKGROUND. The human prostate carcinoma cell line, LNCaP, proliferates under stimulation by a limited number of mitogenic signals, which include members of the growth factor and steroid hormone families. Androgens and epidermal growth factor (EGF) are among the LNCaP cell mitogens. We tested t

Human PARM-1 is a novel mucin-like, andr
✍ Cathrine Fladeby; Shailly N. Gupta; Nicolas Barois; Petri I. Lorenzo; Jeremy C. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 335 KB 👁 2 views

## Abstract In this paper we characterize hPARM‐1, the human ortholog of rat PARM‐1 (prostatic androgen‐repressed message‐1) and demonstrate its role in prostate cancer. Immunofluorescence microscopy and ultrastructural analysis revealed the localization of hPARM‐1 to Golgi, plasma membrane and the